Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer
Trial ID or NCT#
NCT00368329
Status
NOT RECRUITING
Purpose
To study the safety and feasibility of stereotactic radiation dose escalation following neoadjuvant chemotherapy with concurrent conventionally fractionated radiation, by evaluating the acute and late toxicity of treatment.
Official Title
Phase I Study of Dose Escalation Using Image-guided Radiotherapy to Deliver a Stereotactic Radiosurgical Boost After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Esophageal Cancer
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
Edward Graves
Jeffrey Norton, MD
Lei Xing
George A. Fisher Jr.
Medical oncologist,
Gastrointestinal specialist
Colleen Haas Chair in the School of Medicine
Teri A Longacre
Pathologist,
Surgical pathologist,
Immunodiagnosis pathologist
Richard L. Kempson, MD, Professor in Surgical Pathology
Contact us to find out if this trial is right for you.
Contact
Laurie Ann Columbo
6507360792
View on ClinicalTrials.gov
